Wu Zhuang

Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial

Shun Lü, Jie Wang, Yan Yu et al. · Journal of Thoracic Oncology · 2021 · 278 citations · Full text

Medicine, Oncology, Pharmacology +17

Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial

Ying Cheng, Jianhua Chen, Wei Zhang et al. · Nature Medicine · 2024 · 121 citations · Full text

Medicine, Oncology, Pharmacology +16

Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer

Gen Lin, Xirong Fan, Weifeng Zhu et al. · Oncotarget · 2017 · 84 citations · Full text

Medicine, Oncology, Pathology +17

Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study

Qing Zhou, Xiangjiao Meng, Longhua Sun et al. · Journal of Thoracic Oncology · 2024 · 47 citations · Full text

Medicine, Oncology, Pharmacology +10

Sacituzumab Tirumotecan in EGFR-TKI–Resistant, <i>EGFR</i> -Mutated Advanced NSCLC

Wenfeng Fang, Lin Wu, Xiangjiao Meng et al. · New England Journal of Medicine · 2025 · 40 citations

Medicine, Oncology, Pharmacology +17